The Indian Council for Medical Research (ICMR) tie-up with Bharat Biotech to develop indigenous COVID-19 vaccine. The vaccine is to be developed using virus strains that have been isolated from COVD-19 patients at ICMR’s National Institute of Virology (NIV), Pune.
Click Here To Get Test Series For SBI PO 2020
ICMR has shared one of the 11 virus strains that it managed to culture with Bharat Biotech. The industry partnership is to develop the vaccine candidate and ICMR has transferred the technology to them One of the strains has now been successfully transferred from NIV to Bharat Biotech International Ltd. (BBIL) in Hyderabad as part of the partnership. ICMR-NIV will provide continuous support to BBIL for vaccine development.
Important takeaways for all competitive exams:
World AIDS Vaccine Day, also known as HIV Vaccine Awareness Day, is observed annually on…
The Indian government has announced plans for public sector companies like Coal India, NMDC, and…
In April, India's merchandise exports saw a modest 1% increase, reaching $34.99 billion, driven by…
The Open Network for Digital Commerce (ONDC), a digital infrastructure initiative launched in 2021, has…
In response to rising credit demand and falling liquidity, State Bank of India (SBI) has…
The Indian Army is poised to elevate its air defense capabilities with the impending delivery…